mBC-focused research made up only 7% of the $15 billion invested in breast cancer research by major government and nonprofit funders in North America and the United Kingdom.
Metastatic Breast Cancer Alliance Report Finds Research for the Disease Is Underfunded, Details Gaps in Patient ServicesJo Cavallo
Immunocytochemical or molecular assays allow the detection of single disseminated tumor cells (DTCs) in the bone marrow (BM) or the peripheral blood in 10% to 60% of breast cancer patients without signs of metastasis. Results from recently reported studi
Breast cancer Lung cancer Prostate cancer Kidney cancer Thyroid cancer Metastatic bone disease can weaken and damage the bone, making patients prone to fractures. Metastatic bone disease often affects the spine, skull, ribs, pelvis, arms and legs. ...
Breast cancer is a common female malignant About 30% per-year of patients with breast cancer has the phenomenon of malignant cell matastasis,which results in the increasing morbidity and mortality as well as the main factor affecting its therapeutic effect.Recognation of metastasis /invasion related...
Breast cancer is the second leading cause of cancer deaths and approximately one in eight women in the USA will develop breast cancer during their lifetime [1]. Breast cancer cells frequently metastasize to the bone, where the 5-year relative survival rate is < 10% [1]. ...
My head was spinning. I’d never heard these things from anyone before. I’d never had to research breast cancer. My father’s mother died when I was five years old. My grandmother who loved me so dearly. I was the daughter she dreamed of having her entire life. I have her ...
To date, Rebecca has raised over $500k in just 6 months — and all of this has been done while Rebecca herself has gone through 11 surgeries and chemo, etc., from her Stage 3 Breast Cancer diagnosis. Why should I support Bake It Happen and research funding for metastatic breast cancer?
Jane L. Meisel, MD, shares data from a study on communication challenges between providers and patients with metastatic breast cancer regarding TRAEs.
Targeted therapies that can inhibit fusion proteins have been approved for use in a wide variety of cancers, but the prevalence and role of fusion RNAs in breast cancer has not been as comprehensively mapped, Priedigkeit said. Ad He and his colleagues performed a retrospective study using RNA ...